Sujal Shah Cyma Bay Therapeutics, Inc. (CBAY) insider trading activity
Sujal Shah is Chief Executive Officer of CymaBay Therapeutics, Inc.. Currently has a direct ownership of 0 shares of CBAY, which is worth approximately $0. The most recent transaction as insider was on Mar 22, 2024, when has been sold 406,670 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
100.0%
12M change
Total Value Held
$0
Sujal Shah Transaction History
SS
Sujal Shah
Chief Executive Officer
Newark, CA